Add like
Add dislike
Add to saved papers

Reduction and immobilization of hexavalent chromium in chromite ore processing residue using amorphous FeS 2 .

In this work, a series of long-term treatment trials were conducted to evaluate the remediation performance of amorphous iron pyrite (FeS2( am) ) toward hexavalent chromium (Cr(VI)) in chromite ore processing residue (COPR). The effectiveness of FeS2( am) was assessed using alkaline digestion, the synthetic precipitation leaching procedure (SPLP) and the physiologically based extraction test (PBET). Reaction mechanisms were explored by monitoring the changes in the solid pH, redox potential (Eh), the chemical states of relevant elements as well as the crystal forms present in COPR. The results showed that, using a proper dosage, the total content of Cr and Cr(VI) in the leachate from treated COPR met the Chinese standard regulatory limits for the extraction toxicity of hazardous wastes (GB 5085.3-2007). In addition, the in vitro bioaccessibility of Cr(VI) in COPR was also significantly reduced. Moreover, the remediation effect was maintained for the subsequent six months. This long-term effect was attributed to the presence of reductive sulfur (S) species and Fe(II) that remained even after 180 days of treatment, which were identified using high-resolution X-ray photoelectron spectroscopy (HR-XPS) and X-ray diffraction (XRD). To maximize the effect of FeS2( am) , 5% lime was employed as an additive to adjust the pH and thus contributed to Cr(VI) reduction and immobilization. To remediate COPR within 30 days, the use of 5% lime and a specific FeS2( am) dosage (FeS2( am) :Cr(VI) = 1.25:1) is recommended based on the results. For rapid remediation (< 1 day), the use of 5% lime and a 2.5:1 FeS2( am) :Cr(VI) ratio is recommended. In comparison with widely studied reductants, FeS2( am) showed excellent efficiency for the remediation of COPR over both short- and long-term treatment trials, demonstrating it is a very promising alternative treatment method.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app